Bayer Statement on U.S. Food and Drug Administration Advice for Patients: Serious Errors with Certain Blood Glucose Monitoring Test Strips
Posted on: Thursday, 13 August 2009, 19:58 CDT
TARRYTOWN, N.Y., Aug. 13 /PRNewswire/ -- Since 2006, Bayer Diabetes Care has not distributed test strips that use GDH-PQQ (glucose dehydrogenase pyrroloquinoline quinone) glucose monitoring technology for its blood glucose meters. As referenced in a U.S. Food and Drug Administration Advice for Diabetic Patients and their Caregivers issued today, blood glucose meters that use GDH-PQQ technology may "produce a falsely high (elevated) blood glucose result."
Bayer Diabetes Care is committed to patient safety and has a portfolio of blood glucose meters that all meet the current FDA requirements. The company adheres to and supports the highest standard of quality in its meters and strives to do everything possible by a manufacturer to ensure the accuracy of readings. Bayer Diabetes Care meters are designed to minimize the impact from as many external variants as possible, helping to ensure accuracy of readings. Bayer's BREEZE(R)2 and CONTOUR(R) systems both feature No Coding(TM) technology, and no interference with common substances including the non-glucose sugars maltose and galactose.
For more information on Bayer Diabetes Care blood glucose monitoring systems, visit www.bayerdiabetes.com.
SOURCE Bayer Diabetes Care
Source: PR Newswire
Related Articles
- Self Monitoring Of Blood Glucose Levels Helps Patients With Diabetes
- Blood Glucose Control Vital as Childhood Diabetes is set to Double
- Bayer's CONTOUR and Bayer's BREEZE2 Blood Glucose Monitoring Systems Do Not Use Problematic GDH-PQQ Technology
- Data From Pooled Analyses Demonstrates Welchol, Combined With Metformin -- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults With Type 2 Diabetes
- Photo: Welchol(TM) (Colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults With Type 2 Diabetes
- Welchol(TM) (Colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults With Type 2 Diabetes
- Cardiocom(TM) Introduces GlucoCom(TM) Blood Glucose Telemonitoring System to Help Diabetics Improve Glycemic Control
- Frutarom Signs Agreement for Exclusive Global License to Produce and Market a Unique Plant Extract to Reduce and Stabilize Glucose Levels in Blood of Diabetes and Pre-Diabetes Patients
- New Study Shows GlycoMark Blood Test is Most Effective Monitor of After-Meal Glucose Levels in Patients With Diabetes
- Abbott Launches First Complete Blood Glucose Monitoring System Designed for Diabetic Cats and Dogs
 |
 |
User Comments (0)
RSS Feeds